Discovery of Potent and Selective Agonists for the Free Fatty Acid Receptor 1 (FFA1/GPR40), a Potential Target for the Treatment of Type II Diabetes

被引:108
作者
Christiansen, Elisabeth [1 ]
Urban, Christian [2 ]
Merten, Nicole [3 ]
Liebscher, Kathrin [4 ]
Karlsen, Kasper K. [1 ]
Hamacher, Alexandra [2 ]
Spinrath, Andreas [3 ]
Bond, Andrew D. [1 ]
Drewke, Christel [3 ]
Ullrich, Susanne [4 ]
Kassack, Matthias U. [2 ]
Kostenis, Evi [3 ]
Ulven, Trond [1 ]
机构
[1] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark
[2] Univ Dusseldorf, Inst Pharmaceut & Med Chem, D-40225 Dusseldorf, Germany
[3] Univ Bonn, Inst Pharmaceut Biol, Dept Mol Cellular & Pharmacobiol, D-53115 Bonn, Germany
[4] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-72076 Tubingen, Germany
基金
英国医学研究理事会;
关键词
D O I
10.1021/jm8010178
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 4-phenethynyldihydrocinnamic acid agonists of the free fatty acid receptor 1 (FFA(1)) has been discovered and explored. The preferred compound 20 (TUG-424, EC50 = 32 nM) significantly increased glucose-stimulated insulin secretion at 100 nM and may serve to explore the role of FFA(1) in metabolic diseases such as diabetes or obesity.
引用
收藏
页码:7061 / 7064
页数:4
相关论文
共 25 条
[1]  
[Anonymous], 2008, LANCET, V371, P1723, DOI [10.1056/NEJMOA0707193, 10.1016/S0140-6736(08)60733-3]
[2]   Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules [J].
Briscoe, Celia P. ;
Peat, Andrew J. ;
McKeown, Stephen C. ;
Corbett, David F. ;
Goetz, Aaron S. ;
Littleton, Thomas R. ;
McCoy, David C. ;
Kenakin, Terry P. ;
Andrews, John L. ;
Ammala, Carina ;
Fornwald, James A. ;
Ignar, Diane M. ;
Jenkinson, Stephen .
BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) :619-628
[3]   The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids [J].
Briscoe, CP ;
Tadayyon, M ;
Andrews, JL ;
Benson, WG ;
Chambers, JK ;
Eilert, MM ;
Ellis, C ;
Elshourbagy, NA ;
Goetz, AS ;
Minnick, DT ;
Murdock, PR ;
Sauls, HR ;
Shabon, U ;
Spinage, LD ;
Strum, JC ;
Szekeres, PG ;
Tan, KB ;
Way, JM ;
Ignar, DM ;
Wilson, S ;
Muir, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (13) :11303-11311
[4]   The long-chain fatty acid receptor, GPR40, and glucolipotoxicity: investigations using GPR40-knockout mice [J].
Brownlie, Ruth ;
Mayers, Rachel M. ;
Pierce, Jackie A. ;
Marley, Anna E. ;
Smith, David M. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 :950-954
[5]   Label-free cell-based assays for GPCR screening [J].
Fang, Ye ;
Frutos, Anthony G. ;
Verklereen, Ronald .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2008, 11 (05) :357-369
[6]   Synthesis and activity of small molecule GPR40 agonists [J].
Garrido, DM ;
Corbett, DF ;
Dwornik, KA ;
Goetz, AS ;
Littleton, TR ;
McKeown, SC ;
Mills, WY ;
Smalley, TL ;
Briscoe, CP ;
Peat, AJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (07) :1840-1845
[7]   Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release [J].
Hamid, YH ;
Vissing, H ;
Holst, B ;
Urhammer, SA ;
Pyke, C ;
Hansen, SK ;
Glümer, C ;
Borch-Johnsen, K ;
Jorgensen, T ;
Schwartz, TW ;
Pedersen, O ;
Hansen, T .
DIABETIC MEDICINE, 2005, 22 (01) :74-80
[8]   Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 [J].
Itoh, Y ;
Kawamata, Y ;
Harada, M ;
Kobayashi, M ;
Fujii, R ;
Fukusumi, S ;
Ogi, K ;
Hosoya, M ;
Tanaka, Y ;
Uejima, H ;
Tanaka, H ;
Maruyama, M ;
Satoh, R ;
Okubo, S ;
Kizawa, H ;
Komatsu, H ;
Matsumura, F ;
Noguchi, Y ;
Shinobara, T ;
Hinuma, S ;
Fujisawa, Y ;
Fujino, M .
NATURE, 2003, 422 (6928) :173-176
[9]  
Kassack MU, 2002, J BIOMOL SCREEN, V7, P233
[10]   The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding [J].
Kebede, Melkam ;
Alquier, Thierry ;
Latour, Martin G. ;
Semache, Meriem ;
Tremblay, Caroline ;
Poitout, Vincent .
DIABETES, 2008, 57 (09) :2432-2437